Please assess the completion status of the following clinical trial:

Trial Title: Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or Female ages 30 to 80~* Participant is on a low dose statin for at least 6 weeks prior to screening or is statin-naive at screening~Exclusion Criteria:~* Participant has human immunodeficiency virus (HIV), Hepatitis B or C~* Participant uses illegal drugs~* Participant has Type I diabetes~* Participant has a history of claustrophobia

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 10 mg Atorvastatin (Type: ACTIVE_COMPARATOR): 10 mg atorvastatin + placebo
- 80 mg Atorvastatin (Type: ACTIVE_COMPARATOR): 80 mg atorvastatin + placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).